Intramolecular hydrogen bonding: A potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase
- 1 April 2012
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 20 (7), 2435-2443
- https://doi.org/10.1016/j.bmc.2012.01.037
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM049725)
This publication has 47 references indexed in Scilit:
- Peripheral but crucial: A hydrophobic pocket (Tyr706, Leu337, and Met336) for potent and selective inhibition of neuronal nitric oxide synthaseBioorganic & Medicinal Chemistry Letters, 2010
- Potent, Highly Selective, and Orally Bioavailable Gem-Difluorinated Monocationic Inhibitors of Neuronal Nitric Oxide SynthaseJournal of the American Chemical Society, 2010
- Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthaseBioorganic & Medicinal Chemistry, 2010
- Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeabilityBioorganic & Medicinal Chemistry Letters, 2010
- A cellular model for screening neuronal nitric oxide synthase inhibitorsAnalytical Biochemistry, 2009
- Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailabilityBioorganic & Medicinal Chemistry, 2009
- Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsyAnnals of Neurology, 2009
- Design of Selective Neuronal Nitric Oxide Synthase Inhibitors for the Prevention and Treatment of Neurodegenerative DiseasesAccounts of Chemical Research, 2009
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973